CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease von MULLINS, Irene M, SLINGLUFF, Craig L, LEE, Jae K, GARBEE, Courtney F, JIANFEN SHU, ANDERSON, Sara G, MAYER, Melanie E, KNAUS, William A, MULLINS, David W

Volltext

Competition among peptides in melanoma vaccines for binding to MHC molecules von THOMPSON, Lee W, GARBEE, Courtney F, HIBBITTS, Sarah, BRINCKERHOFF, Laurence H, PIERCE, Richard A, CHIANESE-BULLOCK, Kimberly A, DEACON, Donna H, ENGELHARD, Victor H, SLINGLUFF, Craig L

Volltext

MAGE-A1-, MAGE-A10-, and gp100-Derived Peptides Are Immunogenic When Combined with Granulocyte-Macrophage Colony-Stimulating Factor and Montanide ISA-51 Adjuvant and Administered a... von Chianese-Bullock, Kimberly A, Pressley, Jennifer, Garbee, Courtney, Hibbitts, Sarah, Murphy, Cheryl, Yamshchikov, Galina, Petroni, Gina R, Bissonette, Eric A, Neese, Patrice Y, Grosh, William W, Merrill, Priscilla, Fink, Robyn, Woodson, Elizabeth M. H, Wiernasz, Catherine J, Patterson, James W, Slingluff, Craig L., Jr

Volltext

CXC Chemokine Receptor 3 Expression by Activated CD8 super(+) T cells Is Associated with Survival in Melanoma Patients with Stage III Disease von Mullins, Irene M, Slingluff, Craig L, Lee, Jae K, Garbee, Courtney F, Shu, Jianfen, Anderson, Sara G, Mayer, Melanie E, Knaus, William A, Mullins, David W

Volltext